Skip to content
10-Q

Quarterly Report

European Biotech Acquisition Corp.

0001193125-22-284207

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$595.65K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$480.97K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $272.63K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $868.28K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$6.04M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$5.07M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$5.18M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$6.69M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$6.24M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$7.44M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$7.36M
Stockholders Equity Q3 2022 · Jan 7, 2021 $0
Current Liabilities Q3 2022 · Sep 30, 2022 $1.35M
Current Liabilities Q3 2022 · Dec 31, 2021 $505.2K
Total Liabilities Q3 2022 · Sep 30, 2022 $6.53M
Total Liabilities Q3 2022 · Dec 31, 2021 $7.61M
Current Assets Q3 2022 · Sep 30, 2022 $384.53K
Current Assets Q3 2022 · Dec 31, 2021 $916.47K
Total Assets Q3 2022 · Sep 30, 2022 $128.7M
Total Assets Q3 2022 · Dec 31, 2021 $128.47M
Sga Expense Q3 2022 · Sep 30, 2022 $955.28K
Sga Expense Q3 2022 · Sep 30, 2022 $1.47M
Sga Expense Q3 2022 · Sep 30, 2021 $193.34K
Sga Expense Q3 2022 · Sep 30, 2021 $418K
Net Income Q3 2022 · Sep 30, 2022 −$400.02K
Net Income Q3 2022 · Sep 30, 2022 $1.31M
Net Income Q3 2022 · Jun 30, 2022 $200.69K
Net Income Q3 2022 · Mar 31, 2022 $1.51M
Net Income Q3 2022 · Sep 30, 2021 $1.2M
Net Income Q3 2022 · Sep 30, 2021 $1.93M
Net Income Q3 2022 · Jun 30, 2021 $473.52K
Net Income Q3 2022 · Mar 31, 2021 $254.84K
Operating Income Q3 2022 · Sep 30, 2022 −$1.02M
Operating Income Q3 2022 · Sep 30, 2022 −$1.65M
Operating Income Q3 2022 · Sep 30, 2021 −$253.34K
Operating Income Q3 2022 · Sep 30, 2021 −$558K